Highest-materiality recent filing
Alignment Healthcare Q1 revenue $1.24B (+33% YoY); raises full-year guidance
Total revenue $1.235B (+33.3% YoY); health plan membership ~284,800 (+30.9% YoY).
Selling Stockholder sold 13,167,733 shares of common stock via J.P. Morgan Securities LLC.
Alignment Healthcare beats Q4 and FY2025 guidance; FY2026 revenue guide $5.14-5.19B
Q4 revenue $1,012.8M (+44.4% YoY); FY2025 revenue $3,948.7M (+46.1% YoY).
Alignment Healthcare reports 31% membership growth to 275,300; guides 2026 membership 290k-296k
Health plan members as of Jan 1, 2026: ~275,300, up 31% year-over-year.
Alignment Healthcare beats Q3 guidance, revenue $993.7M (+43.5% YoY), raises FY outlook
Q3 revenue $993.7M (+43.5% YoY); health plan membership 229,600 (+25.9% YoY).
Alignment Healthcare Q2 revenue $1.015B (+49% YoY); raises full-year outlook
Total revenue of $1,015.3M, up 49.0% YoY; health plan membership 223,700, up 27.8% YoY.
Alignment Healthcare Q1 revenue up 47.5% to $926.9M; raises 2025 guidance; CFO transition
Q1 revenue $926.9M (+47.5% YoY); MA membership ~217,500 (+31.7% YoY).
Alignment Healthcare reports Q4 revenue $701M (+51% YoY); 2025 guidance $3.72-3.78B
Members 189,100 (+58.6% YoY) beating year-end expectations; 2025 guidance 227K-233K.
Alignment Healthcare sees 35% membership growth, 2025 outlook; promotes Dawn Maroney to President
Health plan membership as of Jan 1, 2025: 209,900, up 35% year-over-year.
Alignment Healthcare closes $330M convertible notes offering, repays $215M term loan
Sold $330M aggregate principal of 4.25% Convertible Senior Notes due 2029.
Alignment Healthcare issues $330M 4.25% convertible notes due 2029; proceeds to repay term loan
Issued $330M aggregate principal of 4.25% Convertible Senior Notes due 2029; net proceeds ~$321M.
Alignment Healthcare Q3 revenue up 51.6% YoY to $692.4M; raises membership and revenue guidance
Revenue $692.4M, up 51.6% YoY; health plan membership ~182,300, up 57.7% YoY.
Two directors resign from Alignment Healthcare board; Margolis enters consulting role
Jeffrey Margolis and Thomas Carella resigned from board effective Aug 13-14, 2024; board reduced from 11 to 9 directors.
Alignment Healthcare Q2 revenue up 47% to $681M; raises year-end guidance
Q2 revenue $681.3M (+47.3% YoY); health plan membership 175,100 (+56.1% YoY).
Alignment Healthcare Q1 revenue $628.6M (+43.1% YoY); membership up 50.5% to 165,100
Revenue ex-ACO REACH $627.6M, up 54.2% YoY; medical benefits ratio 90.9%.
Total revenue $1.82B for FY2023, up 27.2% YoY; health plan members 119,200 at year end, up 21.1% YoY.
Estimates approximately 155,500 Health Plan Members as of January 1, 2024, representing 44% year-over-year growth.
Total revenue $456.7M (+26.7% YoY); health plan membership ~115,600 (+18% YoY).
Alignment Healthcare grants performance-based RSUs to executives; CEO target 2.18M shares
CEO John Kao receives threshold 1,088,667, target 2,177,333, max 3,266,000 PSUs tied to 2024 performance.
Appoints Hyong (Ken) Kim, M.D., as CMO; $560k salary, $2.5M RSU grant, target bonus 85%
Dr. Kim returns to Alignment Healthcare having previously served as CMO from June 2013 to March 2018.
Alignment Healthcare beats Q2 guidance; revenue up 26% to $462.4M, members +17%
Revenue $462.4M (+26.2% YoY); health plan premium revenue $424.7M (+21% YoY).
Alignment Healthcare Q1 revenue $439.2M (+27.1% YoY), membership 109,700, beats guidance on all KPIs
Total revenue $439.2M, up 27.1% YoY; health plan premium revenue $399.7M (+20.8% YoY).
Alignment Healthcare reports 2022 revenue of $1.43B, up 23% YoY; guides 2023 revenue $1.705-1.73B
Q4 revenue $361.8M (+21.3% YoY); health plan membership 98,400 (+14.3%).
Estimated 108,300 Health Plan Members as of Jan 1, 2023, up ~17% YoY; excludes ~7,500 ACO REACH members.
Alignment Healthcare Q3 revenue up 22.8% to $360.3M; raises full-year guidance
Q3 revenue $360.3M (+22.8% YoY); health plan membership ~98,000 (+14% YoY).
Selling stockholders offer 9,000,000 shares of common stock in an underwritten offering.
Alignment Healthcare enters $250M term loan facility, repays $159.3M existing debt
Initial $165M drawn Sep 2, 2022; up to $85M delayed draw available through Sep 2027.
Alignment Healthcare Q2 revenue $366.5M (+18.6% YoY); raises FY 2022 guidance
Health plan membership 95,900, up 13.2% YoY; medical benefits ratio 83.4%, lowest since IPO.
Alignment Healthcare beats Q1 guidance; revenue up 29.4% to $345.5M
Total revenue $345.5M, up 29.4% YoY; health plan premium revenue $330.9M, up 25%.
Alignment Healthcare Q4 revenue $298.3M (+23%), net loss $47.8M; guides FY2022
Q4 2021 revenue $298.3M, +23% YoY; health plan membership 86,100, +26%.
Q4 2021 inpatient utilization estimated at ~155 admissions per thousand, ~5% better than November 4 guidance.
Alignment Healthcare Q3 revenue $293.5M (+18% YoY); net loss $45.8M vs profit year ago
Health plan membership ~86,000, up 29% YoY; medical benefit ratio 85.7% vs 76.7% in Q3 2020.
On April 9, 2025, Hakan Kardes, Chief Experience Officer of Alignment Healthcare, Inc. (the “Company”), notified the Company of his intention to resign his employment with the Company to pursue other professional opportunities.
On January 13, 2025, Alignment Healthcare, Inc. (the “Company”) announced that Dawn Maroney has been promoted to President of the Company, effective immediately
On August 13, 2024 and August 14, 2024, respectively, Jeffrey Margolis and Thomas Carella each notified the Board of Directors (the "Board") of Alignment Healthcare, Inc. (the "Company") of their decision to resign as a member of the Board, effective immediately.
On August 13, 2024 and August 14, 2024, respectively, Jeffrey Margolis and Thomas Carella each notified the Board of Directors (the "Board") of Alignment Healthcare, Inc. (the "Company") of their decision to resign as a member of the Board, effective immediately.
Pursuant to the Amendment, Mr. Konowiecki will no longer serve in an executive role leading strategic network and business development (the "Executive Role"), effective as of December 31, 2023
On September 6, 2023, Alignment Healthcare, Inc. (the “Company”) announced that Hyong (Ken) Kim, M.D., will serve as its Chief Medical Officer, effective as of September 25, 2023.
On August 9, 2023, Alignment Healthcare, Inc. (the "Company") and Dr. Dinesh Kumar reached a mutual agreement of employment separation, pursuant to which Dr. Kumar will no longer serve as the Company’s Chief Medical and Operating Officer, effective as of October 1, 2023 (the “Effective Date”).
On July 11, 2023, Mr. Richard Cross, Senior Vice President, General Counsel and Corporate Secretary of Alignment Healthcare, Inc. (the “Company”), informed the Company that he plans to retire from his position effective as of September 1, 2023 (the “Effective Date”).
mutually agreed to terminate his employment as President, New Markets and Chief Business Officer of the Company, effective as of April 1, 2022.
On December 23, 2021, the Board of Directors of Alignment Healthcare, Inc. (the “Company”) elected Jody Bilney and Yon Yoon Jorden as directors, effective as of January 1, 2022.
On December 23, 2021, the Board of Directors of Alignment Healthcare, Inc. (the “Company”) elected Jody Bilney and Yon Yoon Jorden as directors, effective as of January 1, 2022.
Max materiality 0.90 · Median 0.60 · Most common event earnings